lymphir
(denileukin diftitox-cxdl)Citius Pharmaceuticals, Inc.
Usage: LYMPHIR is indicated for adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma (CTCL) following at least one prior systemic therapy.
4 results
methotrexate
(Methotrexate)Chartwell RX, LLCUsage: Methotrexate tablets are indicated for treating neoplastic diseases (acute lymphoblastic leukemia, mycosis fungoides, relapsed non-Hodgkin lymphomas), rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in pediatric patients, and severe psoriasis in adults.methotrexate
(METHOTREXATE)Alembic Pharmaceuticals Inc.Usage: Methotrexate tablets are indicated for treating acute lymphoblastic leukemia in adults and children, mycosis fungoides in adults, relapsed non-Hodgkin lymphomas, rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in children, and severe psoriasis in adults.targretin
(bexarotene)Bausch Health US, LLCUsage: TARGRETIN® (bexarotene) Capsules are indicated for treating cutaneous manifestations of cutaneous T-cell lymphoma in patients who have not responded to at least one prior systemic therapy.